Clinical Trials Logo

Pulmonary Disease clinical trials

View clinical trials related to Pulmonary Disease.

Filter by:

NCT ID: NCT02981277 Completed - Pulmonary Disease Clinical Trials

Transcricoid Injection vs. Spray as You go Method for Local Anaesthesia During Bronchoscopy

CRISP
Start date: January 1, 2016
Phase: N/A
Study type: Interventional

Flexible bronchoscopy is one of the most widely performed procedures for diagnosis of various bronchopulmonary diseases. Most patients tolerate the procedure well although cough is often reported as a distressing symptom. It is likely that the acceptance of bronchoscopy would be significantly improved with control of cough. Use of sedation during bronchoscopy has been reported to improve procedure tolerance. However, awake(no sedation) bronchoscopy is routinely performed at many centres including ours. Topical lignocaine is administered during bronchoscopy for local anaesthesia. There is limited literature on the efficacy of transtracheal/transcricoid injection versus spray as you go method for lignocaine delivery to the airways during bronchoscopy. This study would help to determine the procedure comfort for the patient while using the transtracheal/transcricoid method vs the spray as you go method.

NCT ID: NCT02981264 Completed - Pulmonary Disease Clinical Trials

Transcricoid Injection vs. Spray as You go Method for Local Anaesthesia During EBUS-TBNA

CRISPEN
Start date: January 1, 2017
Phase: N/A
Study type: Interventional

Endobronchial Ultrasound Guided Transbronchial Needle Aspiration (EBUS -TBNA) is commonly performed for diagnosis of mediastinal pathologies. The procedure can either be performed under general anaesthesia or under moderate sedation with topical anaesthesia. Most patients tolerate the procedure well although cough is often reported as a distressing symptom. Topical lignocaine is administered during endobronchial ultrasound for local anaesthesia. There is limited literature on the efficacy of transtracheal/transcricoid injection versus spray as you go method for lignocaine delivery to the airways during EBUS-TBNA. This study would help to determine the procedure comfort for the patient while using the transtracheal/transcricoid method vs the spray as you go method.

NCT ID: NCT02862418 Recruiting - Pulmonary Disease Clinical Trials

Imaging of Lungs With a New Type of Magnetic Resonance Imaging (MRI) Called UTE (Ultrashort Echo Time)

Start date: October 2015
Phase:
Study type: Observational

This research study has 2 purposes: 1. To learn about new ways to use Magnetic Resonance Imaging (MRI) to take clearer pictures of the lungs. A type of MRI called Ultra Short Echo Time (UTE) will be used as well as traditional MRI. 2. To collect images and health information about lungs that have different kinds of lung diseases to compare to healthy lungs. This collection will help researchers and clinicians to better understand lung variations in health and disease. This study will involve one MRI session that will take about 10 to 30 minutes and for some participants a breathing test that measures how well the lungs are working. This test is called spirometry.

NCT ID: NCT02836912 Completed - Pulmonary Disease Clinical Trials

The Efficacy of Pulmonary Rehabilitation Exercise in Home Care for the Non-invasive Ventilator-dependent Elderly With COPD

Start date: December 4, 2015
Phase: N/A
Study type: Interventional

Pulmonary rehabilitation exercise is beneficial for individuals with chronic obstructive pulmonary disease (COPD). However, merely 30% patients know how to do the exercise correctly. Therefore, it is worthy to investigate the applications in clinical practice. In addition, there are no relative research in Taiwan to see effects of an 8-week pulmonary rehabilitation exercise in home care for the non-invasive ventilator-dependent elderly with COPD.

NCT ID: NCT02826239 Recruiting - Pulmonary Disease Clinical Trials

Evaluation of Postural Effects on Multiple-breath-washout Derived Lung Function Parameters

Start date: February 2016
Phase:
Study type: Observational

The investigators aim to evaluated the effect of postural changes on novel lung function parameters derived from multiple-breath-washout.

NCT ID: NCT02749448 Active, not recruiting - Pulmonary Disease Clinical Trials

Mesenchymal Stem Cells Therapy for Treatment of Airway Remodeling in Mustard Patients

Start date: February 2015
Phase: Phase 1
Study type: Interventional

Background: Sulfur mustard (SM) is a potent alkylating agent that targets several organs, especially lung tissue. SM exposure leads to serious changes in morphological structure of airway system, which is associated with chronic obstructive pulmonary deficiency following exposure to SM. With extensive progress and achievements in tissue repair through stem cells therapy, consideration of lung tissue has been increased due to the high prevalence of pulmonary problems. Several factors such as selection of cell types, required conditions for growth and proliferation of stem cells, and the process of entering into the body to repair damaged lung tissue are considered as the most important problems in this issue. Accumulating studies, both in animals and human with mesenchymal stem cells (MSC) support the hypothesis of therapeutic effects of these cells in various disorders. In this study investigators aimed to evaluate safety and potential efficacy of systemic MSC administration for treatment of chronic lung injuries in SM-exposed patients. Methods: Patients will receive 100 million MSC cells every two months for three injections within 6 months. After each injection, parameters including safety, pulmonary function testing (PFT), quality-of-life indicators, 6 minute walk test (6MWT), and expression of inflammation and oxidative stress genes will be evaluated.

NCT ID: NCT02740569 Completed - Clinical trials for Sleep Apnea, Obstructive

Obstructive Sleep Apnea in Scleroderma and Pulmonary Involvement

OSASPI
Start date: April 2016
Phase:
Study type: Observational

Scleroderma is an autoimmune disease with skin manifestations and may have pulmonary involvement. Obstructive sleep apnea (OSA) may also be seen in scleroderma. Less is known regarding the prevalence of OSA in scleroderma and its association with pulmonary involvement.

NCT ID: NCT02714933 Completed - Pulmonary Disease Clinical Trials

Thoracic MRI Imaging in Children

ImagINI-CHEST
Start date: February 13, 2017
Phase: N/A
Study type: Interventional

The aim of this study is to compare a new Magnetic Resonance Imaging (MRI)protocol, including a new MRI sequence for visualization of lung parenchyma, to computed tomography as the gold standard for the evaluation of thoracic region in children.

NCT ID: NCT02671669 Completed - Cardiac Disease Clinical Trials

Cardiopulmonary Outpatient Rehabilitation Using Mobile Technology

Start date: January 2016
Phase: N/A
Study type: Interventional

This is a randomized controlled trial of the feasibility and utility of implementing a smartphone application (MVN) to maintain compliance with a Heart Healthy lifestyle after discharge from a cardiac outpatient rehabilitation program. Patients will be randomized into one of two groups: usual care (control: UC) or Movn mobile application (intervention: MVN). This study will improve and strengthen data collection from this at-risk patient population by recording baseline clinical and psycho social measures while gaining insight into self-reporting of physical activity and frequency between the UC and MVN groups.

NCT ID: NCT02612389 Completed - COPD Clinical Trials

Meditative Movement for COPD Symptoms in Non-Smoking Flight Attendants

MMforFA
Start date: March 2015
Phase: N/A
Study type: Interventional

This study will explore the a Qigong based exercise intervention, here referred to as Meditative Movement (MM), to ameliorate the symptoms associated with chronic obstructive pulmonary disease (COPD) and its co-morbidities. It tests the hypothesis that MM will have a beneficial effect on COPD in FA, particularly on functional ability, respiratory symptoms, affective state, inflammation, and autonomic imbalance. If the hypothesis is correct, MM could be rapidly and inexpensively taught to FA with COPD and other COPD patients to slow degeneration and improve quality of life.